Viewing nowCombinationMaxmicah Tablet 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Albogen Korea Co., Ltd.

MFDS item code 201606381 · Approved 2016.10.31 · Insurance code 652606310
Improvement in blood pressure control for essential hypertension
This medication is used for patients with essential hypertension who do not achieve adequate blood pressure control with either amlodipine or telmisartan monotherapy. In other words, it helps to effectively lower blood pressure and reduce the risk of cardiovascular disease. It is used to improve the overall health of patients through blood pressure management.
The recommended dosage of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with mild to moderate renal impairment, dose adjustment is not necessary, but for those with severe renal impairment, treatment should start with a lower dose and be gradually increased. For patients with hepatic impairment, the daily dose of telmisartan should not exceed 40 mg.
Safety and efficacy have not been established for pediatric patients under 18 years of age, so the use of this medication is not recommended.
This medication can pose serious risks to the fetus, especially during the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This medication is contraindicated in patients with certain diseases, such as hepatic impairment, obstructive biliary disease, severe hypotension, heart-related diseases, and patients with severely impaired kidney function or diabetes. Patients with primary aldosteronism or heart valve diseases, patients with decreased liver function, gastrointestinal diseases, renal artery hypertension, and elderly patients require special precautions when taking this medication. Side effects such as dizziness, peripheral edema, and hypotension may commonly occur, and there is a possibility of rare but serious adverse reactions, so any unusual symptoms should be consulted with healthcare professionals immediately. During treatment, regular monitoring of blood pressure, kidney function, electrolyte levels, etc., is necessary to identify any abnormalities, especially paying attention to hyperkalemia and worsening kidney function. This medication may interact with other medications, so if you are taking any other drugs, you must inform your doctor or pharmacist, especially when taken with anticoagulants, diuretics, lithium preparations, grapefruit juice, etc. Caution should be taken when driving or operating machinery due to potential dizziness or drowsiness, and it is advisable to avoid these activities if symptoms are severe. In case of overdose, symptoms such as hypotension, arrhythmias, and acute kidney failure may occur, requiring immediate medical attention. The safety of this medication has not been established in children, and breastfeeding women should avoid taking it. Store this medication out of the reach of children and take it immediately after opening to maintain product quality.
Severe allergic reactions (hives, severe swelling, angioedema, anaphylaxis), severe skin reactions (severe rash, toxic skin rash, Stevens-Johnson syndrome), respiratory problems (dyspnea, interstitial lung disease), liver problems (jaundice, hepatitis, increased liver enzymes), serious neurological symptoms (severe headache, syncope, extrapyramidal disorder, tremors), severe edema or urinary disorders (reduced urine output, severe edema), myocardial infarction, congestive heart failure
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, to maintain its effectiveness, it is important to store it at room temperature between 1 to 30 degrees Celsius.
Biconvex oval double tablet in white to pale yellow and light blue colors
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.